0001847903-24-000095.txt : 20240625 0001847903-24-000095.hdr.sgml : 20240625 20240625161431 ACCESSION NUMBER: 0001847903-24-000095 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240625 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centessa Pharmaceuticals plc CENTRAL INDEX KEY: 0001847903 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40445 FILM NUMBER: 241069112 BUSINESS ADDRESS: STREET 1: 3RD FLOOR STREET 2: 1 ASHLEY ROAD CITY: ALTRINCHAM, CHESHIRE STATE: X0 ZIP: WA14 2DT BUSINESS PHONE: 44 7391 789784 MAIL ADDRESS: STREET 1: 3RD FLOOR STREET 2: 1 ASHLEY ROAD CITY: ALTRINCHAM, CHESHIRE STATE: X0 ZIP: WA14 2DT FORMER COMPANY: FORMER CONFORMED NAME: Centessa Pharmaceuticals Ltd DATE OF NAME CHANGE: 20210224 8-K 1 cnta-20240625.htm 8-K cnta-20240625
FALSE000184790300018479032024-06-252024-06-250001847903us-gaap:CommonStockMember2024-06-252024-06-250001847903cnta:AmericanDepositarySharesMember2024-06-252024-06-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (date of earliest event reported): June 25, 2024
 
CENTESSA PHARMACEUTICALS PLC
(Exact name of Registrant, as specified in its charter)
England and Wales001-4044598-1612294
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
Mailing address:
3rd Floor
1 Ashley Road
Altrincham
Cheshire WA14 2DT
United Kingdom
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: +1 (617) 468-5770
Former name or address, if changed since last report: 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Ordinary shares, nominal value £0.002 per share
 CNTA 
Nasdaq Stock Market, LLC*
American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share
CNTA
Nasdaq Stock Market, LLC
*Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market, LLC.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 25, 2024, the Company held its 2024 Annual General Meeting (the “Annual General Meeting”). Proxies were solicited pursuant to the Company’s definitive proxy statement filed on May 9, 2024 (the “Proxy Statement”), with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended. The number of ordinary shares entitled to vote at the Annual General Meeting was 113,261,213. The number of shares of ordinary shares present or represented by valid proxy at the Annual General Meeting was 88,952,125, thus establishing a quorum for the Annual General Meeting. All matters submitted to a vote of the Company’s shareholders at the Annual General Meeting were approved and the director nominees were elected. The voting results reported below are final.
Ordinary ResolutionsForAgainstWithheldBroker Non-Votes
To re-appoint as a director, Francesco De Rubertis, Ph.D., who retires by rotation in accordance with the Company’s articles of association.67,765,652 8,942,960 12,521,500 — 
To re-appoint as a director, Saurabh Saha, M.D., Ph.D., who retires by rotation in accordance with the Company’s articles of association76,363,186 345,426 12,521,500 — 
To re-appoint as a director, Mary Lynne Hedley, Ph.D., who retires by rotation in accordance with the Company’s articles of association.76,585,872 137,983 12,506,257 — 
To re-appoint KPMG LLP, a United Kingdom entity, as U.K. statutory auditors of the Company, to hold office until the conclusion of the next meeting at which the Company’s annual accounts and reports are laid before the Company.88,878,408 73,717 277,987 — 
To ratify the re-appointment of KPMG LLP, a Delaware limited liability partnership, as the Company’s independent registered public accounting firm, for the financial year ending December 31, 2024.88,878,528 73,597 277,987 — 
To authorize the Audit Committee to determine the Company’s auditors’ remuneration for the financial year ending December 31, 2024.76,668,533 39,513 12,522,066 — 
To receive and adopt our U.K. statutory annual accounts and reports for the financial year ended December 31, 2023 and to note that the Company’s directors do not recommend the payment of any dividend for the financial year ended December 31, 2023.76,699,008 5,731 12,525,373 — 
To receive and approve, on an advisory basis, the Company’s U.K. statutory directors’ remuneration report for the financial year ended December 31, 2023.76,660,977 37,139 12,531,996 — 


Ordinary Resolutions (continued)ForAgainstWithheldBroker Non-Votes
To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the U.K. Companies Act 2006, to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company (“Rights”) up to an aggregate nominal amount of £100,740 for a period expiring (unless previously renewed, varied or revoked by the Company in general meeting) on June 24, 2029, save that the Company may, before such expiry, make an offer or agreement which would or might require shares to be allotted or Rights to be granted and the directors may allot shares or grant Rights in pursuance of such offer or agreement notwithstanding that the authority conferred by this resolution has expired. The authority referred to in this resolution is in addition to all subsisting authorities conferred on the directors of the Company in accordance with section 551 of the U.K. Companies Act 2006, but the directors of the Company may allot shares in the Company or grant Rights pursuant to an offer made or agreement entered into by the Company before the expiry of the authority pursuant to which that offer was made or agreement entered into.67,955,436 8,758,351 12,516,325 — 
Special ResolutionForAgainstWithheldBroker Non-Votes
To generally empower, conditional upon resolution 9 above being duly passed and pursuant to section 570 of the U.K. Companies Act 2006, the directors of the Company or any duly authorised committee of the directors to allot equity securities (within the meaning of the U.K. Companies Act 2006) for cash pursuant to the authority conferred on them by resolution 9 as if section 561 of the U.K. Companies Act 2006 and any pre-emption provisions in the articles of association of the Company (or howsoever otherwise arising) did not apply to the allotment for a period expiring (unless previously renewed, varied or revoked by the Company prior to or on that date) on June 24, 2029 save that the Company may, before such expiry, make an offer or agreement which would or might require shares to be allotted after such expiry and the directors may allot shares in pursuance of any such offer or agreement notwithstanding that the power conferred by this resolution has expired.64,628,145 12,085,438 12,516,529 — 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:    June 25, 2024

 
   
 By:/s/ Saurabh Saha
 Name:Saurabh Saha, M.D., Ph.D.
 Title:Chief Executive Officer


 EX-101.SCH 2 cnta-20240625.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 cnta-20240625_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 cnta-20240625_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Country Entity Address, Country Document Period End Date Document Period End Date Ordinary shares Common Stock [Member] Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town American Depositary Shares American Depositary Shares [Member] American Depositary Shares Country Region Country Region Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Document Type Document Type Amendment Flag Amendment Flag Entity Ex Transition Period Entity Ex Transition Period Class of Stock [Axis] Class of Stock [Axis] Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Registrant Name Entity Registrant Name EX-101.PRE 5 cnta-20240625_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
Jun. 25, 2024
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Jun. 25, 2024
Entity Registrant Name CENTESSA PHARMACEUTICALS PLC
Entity Incorporation, State or Country Code X0
Entity File Number 001-40445
Entity Address, Address Line One 3rd Floor
Entity Address, Address Line Two 1 Ashley Road
Entity Address, Address Line Three Altrincham
Entity Address, City or Town Cheshire
Entity Address, Postal Zip Code WA14 2DT
Entity Address, Country GB
Country Region +1
City Area Code (617)
Local Phone Number 468-5770
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Flag false
Entity Central Index Key 0001847903
Entity Tax Identification Number 98-1612294
Ordinary shares  
Document Information [Line Items]  
Title of 12(b) Security Ordinary shares, nominal value £0.002 per share
Trading Symbol CNTA
Security Exchange Name NASDAQ
American Depositary Shares  
Document Information [Line Items]  
Title of 12(b) Security American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share
Trading Symbol CNTA
Security Exchange Name NASDAQ
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 26 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.cnta.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cnta-20240625.htm cnta-20240625.xsd cnta-20240625_def.xml cnta-20240625_lab.xml cnta-20240625_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cnta-20240625.htm": { "nsprefix": "cnta", "nsuri": "http://www.cnta.com/20240625", "dts": { "inline": { "local": [ "cnta-20240625.htm" ] }, "schema": { "local": [ "cnta-20240625.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "cnta-20240625_def.xml" ] }, "labelLink": { "local": [ "cnta-20240625_lab.xml" ] }, "presentationLink": { "local": [ "cnta-20240625_pre.xml" ] } }, "keyStandard": 26, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 1, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 33, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://www.cnta.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnta-20240625.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnta-20240625.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cnta_AmericanDepositarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cnta.com/20240625", "localname": "AmericanDepositarySharesMember", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "American Depositary Shares", "label": "American Depositary Shares [Member]", "documentation": "American Depositary Shares" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Country Region", "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Three", "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.cnta.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001847903-24-000095-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001847903-24-000095-xbrl.zip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end XML 17 cnta-20240625_htm.xml IDEA: XBRL DOCUMENT 0001847903 2024-06-25 2024-06-25 0001847903 us-gaap:CommonStockMember 2024-06-25 2024-06-25 0001847903 cnta:AmericanDepositarySharesMember 2024-06-25 2024-06-25 false 0001847903 8-K 2024-06-25 CENTESSA PHARMACEUTICALS PLC X0 001-40445 98-1612294 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT GB +1 (617) 468-5770 false false false false Ordinary shares, nominal value £0.002 per share CNTA NASDAQ American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share CNTA NASDAQ true false